𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tamoxifen is safe and effective in gynecological cancer patients with renal dysfunction

✍ Scribed by N. SIRISABYA; Y. LI; A. JAISHUEN; H.G. ZHENG; D.M. GERSHENSON; J.J. KAVANAGH

Book ID
109086271
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
63 KB
Volume
18
Category
Article
ISSN
1048-891X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Amsacrine is safe and effective therapy
Amsacrine is safe and effective therapy for patients with myocardial dysfunction and acute leukemia
✍ Zalmen A. Arlin; Eric J. Feldman; Abraham Mittelman; Tauseef Ahmed; Carmelo Pucc πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 306 KB πŸ‘ 2 views

The role of amsacrine in inducing remission in patients with cardiac disease and acute leukemia was evaluated. There were 17 patients with acute myelogenous leukemia (AML), six with acute lymphocytic leukemia (ALL), and one with biphenotypic leukemia. In this series of 24 patients whose disease had

Imatinib front-line therapy is safe and
Imatinib front-line therapy is safe and effective in patients with chronic myelogenous leukemia with pre-existing liver and/or renal dysfunction
✍ Wei-Gang Tong; Hagop Kantarjian; Susan O'Brien; Stefan Faderl; Farhad Ravandi; G πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 198 KB πŸ‘ 2 views

## Abstract ## BACKGROUND: Imatinib 400 mg daily is the standard treatment for patients with chronic myelogenous leukemia (CML). The safety and efficacy of imatinib in CML patients with pre‐existing liver and/or renal dysfunction has not been analyzed. ## METHODS: The authors analyzed the outcom